A Pfizer Win Against Uncle Sam Could Unleash ‘Gold Rush’ in Sales — and Cost Taxpayers Billions

August 18, 2021

By Jay Hancock
A federal judge is expected to rule any day in Pfizer lawsuit that aims to erase an important control on pharma marketing after decades of regulatory erosion and soaring drug prices. Three years ago, pharma giant Pfizer paid $24 million to settle federal allegations that it was paying kickbacks and inflating sales by reimbursing Medicare patients for out-of-pocket medication costs.

Read the source article at The Most Revolutionary Act
2021-08-10 01:28:39

Share This Story!